- call +1-201-465-4211
- email sales@mrinsights.biz
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss.
Scope of the Report:
This report studies the Tuberculosis (TB) Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tuberculosis (TB) Diagnostics market by product type and applications/end industries.
The increasing number of government and non-government initiatives to eradicate tuberculosis (TB) is expected to be one of the primary drivers for the global tuberculosis (TB) diagnostics market growth till 2023. A global TB control program was introduced by the US Agency for International Development (USAID) in the year 1998. To support the eradication of TB, the US prioritized and provided increased funding for bilateral and multilateral programs in the subsequent decades. Similarly, the division of tuberculosis elimination (DTBE), adopted strategic plans to control TB in the US. These programs reduce the incidence and mortality by 50%.
The increasing prevalence of TB and rising population in APAC is driving the growth prospects for the global tuberculosis (TB) diagnostics market in the region. The governments in the region are motivated to take measures to improve the healthcare infrastructure. They are also extensively focusing on the preventive care due to the rising population, especially in China and India. Furthermore, the enhancement of healthcare infrastructure in countries such as Singapore, Japan, Australia, and South Korea will boost the adoption of tuberculosis diagnostics in the APAC region.
The global Tuberculosis (TB) Diagnostics market is valued at 2040 million USD in 2017 and is expected to reach 2540 million USD by the end of 2023, growing at a CAGR of 3.7% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tuberculosis (TB) Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
BD
bioMérieux
F. Hoffmann-La Roche
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Smear Microscopy
Molecular Testing
Mantoux Tuberculin Test
Culture
Drug Susceptibility Testing
LF-LAM for PLHIV
Market Segment by Applications, can be divided into
Diagnostic Laboratories
Hospitals
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Tuberculosis (TB) Diagnostics Market Overview
1.1 Product Overview and Scope of Tuberculosis (TB) Diagnostics
1.2 Classification of Tuberculosis (TB) Diagnostics by Types
1.2.1 Global Tuberculosis (TB) Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Types in 2017
1.2.3 Smear Microscopy
1.2.4 Molecular Testing
1.2.5 Mantoux Tuberculin Test
1.2.6 Culture
1.2.7 Drug Susceptibility Testing
1.2.8 LF-LAM for PLHIV
1.3 Global Tuberculosis (TB) Diagnostics Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Global Tuberculosis (TB) Diagnostics Market by Regions
1.4.1 Global Tuberculosis (TB) Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Tuberculosis (TB) Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tuberculosis (TB) Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis (TB) Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Tuberculosis (TB) Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis (TB) Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Tuberculosis (TB) Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Tuberculosis (TB) Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 BD
2.2.1 Business Overview
2.2.2 Tuberculosis (TB) Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 bioMérieux
2.3.1 Business Overview
2.3.2 Tuberculosis (TB) Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 bioMérieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 F. Hoffmann-La Roche
2.4.1 Business Overview
2.4.2 Tuberculosis (TB) Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 F. Hoffmann-La Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Thermo Fisher Scientific
2.5.1 Business Overview
2.5.2 Tuberculosis (TB) Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Tuberculosis (TB) Diagnostics Market Competition, by Players
3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis (TB) Diagnostics Players Market Share
3.2.2 Top 10 Tuberculosis (TB) Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Tuberculosis (TB) Diagnostics Market Size by Regions
4.1 Global Tuberculosis (TB) Diagnostics Revenue and Market Share by Regions
4.2 North America Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Tuberculosis (TB) Diagnostics Revenue by Countries
5.1 North America Tuberculosis (TB) Diagnostics Revenue by Countries (2013-2018)
5.2 USA Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Tuberculosis (TB) Diagnostics Revenue by Countries
6.1 Europe Tuberculosis (TB) Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Countries
7.1 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Countries (2013-2018)
7.2 China Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Tuberculosis (TB) Diagnostics Revenue by Countries
8.1 South America Tuberculosis (TB) Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Tuberculosis (TB) Diagnostics by Countries
9.1 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Tuberculosis (TB) Diagnostics Market Segment by Type
10.1 Global Tuberculosis (TB) Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2018-2023)
10.3 Smear Microscopy Revenue Growth Rate (2013-2023)
10.4 Molecular Testing Revenue Growth Rate (2013-2023)
10.5 Mantoux Tuberculin Test Revenue Growth Rate (2013-2023)
10.6 Culture Revenue Growth Rate (2013-2023)
10.7 Drug Susceptibility Testing Revenue Growth Rate (2013-2023)
10.8 LF-LAM for PLHIV Revenue Growth Rate (2013-2023)
11 Global Tuberculosis (TB) Diagnostics Market Segment by Application
11.1 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Tuberculosis (TB) Diagnostics Market Forecast by Application (2018-2023)
11.3 Diagnostic Laboratories Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
12 Global Tuberculosis (TB) Diagnostics Market Size Forecast (2018-2023)
12.1 Global Tuberculosis (TB) Diagnostics Market Size Forecast (2018-2023)
12.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Tuberculosis (TB) Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Tuberculosis (TB) Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Tuberculosis (TB) Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Tuberculosis (TB) Diagnostics Picture
Table Product Specifications of Tuberculosis (TB) Diagnostics
Table Global Tuberculosis (TB) Diagnostics and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
